SCHEMBL17934175

SCHEMBL17934175

COc1ccc(N)c(NCC2(CO)COC2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ KMT2A Q03164 5/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ THRB P10828 3/20 0.36
▸ TDP1 Q9NUW8 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ RECQL P46063 2/20 0.36
▸ BLM P54132 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HDAC3 O15379 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17934171 0.79 SMN1; SMN2 (0.49) ALDH1A1KMT2AMEN1MAPTTDP1
SCHEMBL24732041 0.78 ALDH1A1 (0.47) ALDH1A1CYP3A4KMT2AMEN1MAPT
SCHEMBL3897070 0.75 ALDH1A1 (0.47) ALDH1A1CYP3A4HTR1AKMT2AMEN1
SCHEMBL29624960 0.73 ALDH1A1 (0.48) ALDH1A1CYP3A4HTR1AHTR2BSIGMAR1
SCHEMBL2019104 0.73 ALDH1A1 (0.48) ALDH1A1CYP3A4HTR1AHTR2BSIGMAR1
SCHEMBL2798576 0.72 GAA (0.41) ALDH1A1CYP3A4HTR1AHTR2BSIGMAR1
SCHEMBL12987305 0.72 ALDH1A1 (0.40) ALDH1A1KMT2AMEN1MAPTTDP1
SCHEMBL16406450 0.71 HDAC3 (0.47) ALDH1A1CYP3A4HTR1AKMT2AMEN1
SCHEMBL24329350 0.71 HDAC1 (0.49) ALDH1A1MAPTKDM4EGAASMN1; SMN2
SCHEMBL13728343 0.70 PTGER4 (0.45) ALDH1A1CYP3A4HTR1AHTR2BSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3245200-B1 2-(PYRAZIN-2-YLCARBONYLAMINOMETHYL)BENZIMIDAZOLIUM COMPOUNDS AS EPITHELIAL SODIUM CHANNEL INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2021-03-10 — — EP disclosed
US-9981954-B2 2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-05-29 — — US disclosed
WO-2016113168-A1 2-(PYRAZIN-2-YLCARBONYLAMINOMETHYL)BENZIMIDAZOLIUM COMPOUNDS AS EPITHELIAL SODIUM CHANNEL INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-07-21 — — WO disclosed
Send feedback